Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Kanzhun
BZ
$7.93B
| $7.27M | ﹤0.01% |
202,007
+123,608
| +158% | +$4.37M |
|
|
UXIN
2402
Uxin Ltd
UXIN
$255M
| $7.26M | ﹤0.01% |
26,301
+17,266
| +191% | +$5.7M |
|
|
FLNA
2403
Filana Therapeutics
FLNA
$44.1M
| $7.25M | ﹤0.01% |
116,851
+72,936
| +166% | +$6.09M |
|
|
DADA
2404
DELISTED
Dada Nexus
DADA
| $7.25M | ﹤0.01% |
361,920
+298,019
| +466% | +$6.75M |
|
2405
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.7B
| $7.25M | ﹤0.01% |
+148,854
| New | +$7.36M |
|
|
ANZUU
2406
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
| $7.25M | ﹤0.01% |
733,120
-86,289
| -11% | -$855K |
|
2407
CALL
Royalty Pharma
RPRX
$27.1B
| $7.23M | ﹤0.01% |
200,000
+60,000
| +43% | +$2.33M |
|
2408
Phibro Animal Health
PAHC
$1.54B
| $7.21M | ﹤0.01% |
334,954
+296,811
| +778% | +$7.14M |
|
2409
Photronics
PLAB
$1.66B
| $7.21M | ﹤0.01% |
529,153
+35,447
| +7% | +$481K |
|
2410
CALL
Halliburton
HAL
$29.9B
| $7.21M | ﹤0.01% |
333,300
-361,700
| -52% | -$7.41M |
|
2411
Aspen Aerogels
ASPN
$421M
| $7.2M | ﹤0.01% |
156,510
-286,251
| -65% | -$11.3M |
|
2412
Keros Therapeutics
KROS
$212M
| $7.2M | ﹤0.01% |
181,876
+64,961
| +56% | +$2.31M |
|
|
LFG.WS
2413
CALL
DELISTED
Archaea Energy Inc. Warrants, exercisable for one share of Class A common stock at an exercise price
LFG.WS
| $7.19M | ﹤0.01% |
+980,000
| New | +$7.73M |
|
2414
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $7.19M | ﹤0.01% |
136,680
-66,035
| -33% | -$3.55M |
|
2415
Vir Biotechnology
VIR
$1.91B
| $7.19M | ﹤0.01% |
165,173
-151,977
| -48% | -$6.58M |
|
2416
Helmerich & Payne
HP
$4.25B
| $7.18M | ﹤0.01% |
+261,980
| New | +$7.31M |
|
2417
Bentley Systems
BSY
$11.3B
| $7.18M | ﹤0.01% |
118,410
+82,410
| +229% | +$5.26M |
|
|
DCRDU
2418
DELISTED
Decarbonization Plus Acquisition Corporation IV Unit
DCRDU
| $7.18M | ﹤0.01% |
+711,242
| New | +$7.16M |
|
2419
CALL
InMode
INMD
$855M
| $7.17M | ﹤0.01% |
90,000
+70,000
| +350% | +$4.27M |
|
2420
Fox Factory Holding Corp
FOXF
$888M
| $7.17M | ﹤0.01% |
49,627
-22,179
| -31% | -$3.41M |
|
|
WAVC.U
2421
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
| $7.17M | ﹤0.01% |
+726,805
| New | +$7.2M |
|
2422
AtaiBeckley Inc
ATAI
$2.73B
| $7.17M | ﹤0.01% |
484,425
-35,061
| -7% | -$570K |
|
2423
AdaptHealth
AHCO
$774M
| $7.16M | ﹤0.01% |
307,472
+299,522
| +3,768% | +$7.24M |
|
2424
Energizer
ENR
$1.53B
| $7.16M | ﹤0.01% |
183,360
-331,904
| -64% | -$13.4M |
|
2425
Tower Semiconductor
TSEM
$23.7B
| $7.16M | ﹤0.01% |
239,477
-17,197
| -7% | -$495K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.